CABA
Cabaletta Bio, Inc.
NASDAQ · Healthcare · Biotechnology · US
$3.43
−1.42%Leverage
- Debt / equity
- 0.12x
- Net debt / equity
- -0.95x
- Debt / assets
- 0.10x
- Debt / EBITDA
- -0.15x
- Net debt / EBITDA
- 1.13x
Liquidity & coverage
- Current ratio
- 5.79x
- Quick ratio
- 5.79x
- Cash ratio
- 5.64x
- Interest coverage
- -80.94x
- EBITDA / interest
- -77.19x
- Working capital
- $191.1M
Cash & dividend
- FCF / debt
- -6.00x
- Cash flow / debt
- -5.99x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026